You are here

Article info

Article menu
Download PDFPDF
Drug therapy
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children

Authors

  1. Correspondence to Professor Christoph Rudin, Division of Infectious Diseases, University Children's Hospital UKBB, Roemergasse, 8, Basel CH4058, Switzerland; christoph.rudin{at}unibas.ch
View Full Text

Citation

Rudin C, Wolbers M, Nadal D, et al
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children
Archives of Disease in Childhood 2010;95:478-481.

Publication history

  • Accepted December 22, 2009
  • First published May 25, 2010.
Online issue publication 
March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions